A Phase II Study to Evaluate the Efficacy and Safety of TLC388 in Advanced/Metastatic RCC Patients
Clinical trial NCT01831973 · COMPLETED
Trial details
- NCT number
- NCT01831973
- Sponsor
- Taiwan Liposome Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-30
- Primary completion
- 2015-03-19
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.